Todd C. Cozzens - Sep 2, 2021 Form 4 Insider Report for Natera, Inc. (NTRA)

Role
Director
Signature
/s/ Tami Chen, Attorney-in-Fact
Stock symbol
NTRA
Transactions as of
Sep 2, 2021
Transactions value $
-$2,709,162
Form type
4
Date filed
9/3/2021, 09:49 PM
Previous filing
Jun 15, 2021
Next filing
May 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Options Exercise $3.79K +2.73K +21.04% $1.39* 15.7K Sep 2, 2021 Direct
transaction NTRA Common Stock Options Exercise $132K +11.2K +71.04% $11.80 26.9K Sep 2, 2021 Direct
transaction NTRA Common Stock Options Exercise $110K +10.6K +39.34% $10.41* 37.5K Sep 2, 2021 Direct
transaction NTRA Common Stock Sale -$1.07M -8.84K -23.59% $120.96 28.6K Sep 2, 2021 Direct F1
transaction NTRA Common Stock Sale -$1.3M -10.7K -37.26% $121.96 18K Sep 2, 2021 Direct F2
transaction NTRA Common Stock Sale -$585K -4.76K -16.64% $122.71 23.9K Sep 2, 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTRA Stock Option (right to buy) Options Exercise $0 -2.73K -100% $0.00* 0 Sep 2, 2021 Common Stock 2.73K $1.39 Direct F4
transaction NTRA Stock Option (right to buy) Options Exercise $0 -11.2K -100% $0.00* 0 Sep 2, 2021 Common Stock 11.2K $11.80 Direct F5
transaction NTRA Stock Option (right to buy) Options Exercise $0 -10.6K -94.71% $0.00 591 Sep 2, 2021 Common Stock 10.6K $10.41 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.48 to $121.42 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.50 to $122.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.50 to $123.1050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The option shares vested fully and became exercisable on March 21, 2021.
F5 The option shares vested fully and became exercisable on May 23, 2017.
F6 The option shares vested fully and became exercisable on May 16, 2018.